Minimal Residual Disease in Acute Lymphoblastic Leukemia: Current Practice and Future Directions

SIMPLE SUMMARY: Acute lymphoblastic leukemia minimal residual disease (MRD) refers to the presence of residual leukemia cells following the achievement of complete remission, but below the limit of detection using conventional morphologic assessment. Up to two thirds of children may have MRD detecta...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras Yametti, Gloria Paz, Ostrow, Talia H., Jasinski, Sylwia, Raetz, Elizabeth A., Carroll, William L., Evensen, Nikki A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069391/
https://www.ncbi.nlm.nih.gov/pubmed/33924381
http://dx.doi.org/10.3390/cancers13081847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069391/
https://www.ncbi.nlm.nih.gov/pubmed/33924381
http://dx.doi.org/10.3390/cancers13081847

Ejemplares similares